George Stamatoyannopoulos
Corporate Officer/Principal at University of Washington
George Stamatoyannopoulos active positions
| Companies | Position | Start | End |
|---|---|---|---|
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Career history of George Stamatoyannopoulos
Former positions of George Stamatoyannopoulos
| Companies | Position | Start | End |
|---|---|---|---|
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Director/Board Member | - | - |
| Founder | - | - | |
Regulome Corp.
 Regulome Corp. Pharmaceuticals: MajorHealth Technology Regulome Corp. manufactures pharmaceutical products. It supplies medicines, vitamin supplements, and medical devices for applications in drug and diagnostic discovery development to the supermarket chains. The company was founded in 2001 by George Stamatoyannopoulos and is headquartered in Seattle, WA. | Founder | - | - |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | President | - | - |
| American Society of Gene Therapy | President | - | - |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Director/Board Member | 01/10/2007 | - |
| Founder | 27/08/2009 | - |
Training of George Stamatoyannopoulos
| National & Kapodistrian University of Athens | Doctorate Degree |
Statistics
International
| United States | 7 |
| Greece | 2 |
Operational
| Founder | 3 |
| Director/Board Member | 2 |
| President | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
| American Society of Gene Therapy | |
Regulome Corp.
Regulome Corp. Pharmaceuticals: MajorHealth Technology Regulome Corp. manufactures pharmaceutical products. It supplies medicines, vitamin supplements, and medical devices for applications in drug and diagnostic discovery development to the supermarket chains. The company was founded in 2001 by George Stamatoyannopoulos and is headquartered in Seattle, WA. | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Health Technology |
